CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,720,952
- in 8 filings, $195K under 10b5-1 plans
Net −$9,720,952. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-01 | Kalia Kumud Chief Information Officer | Option exercise · Restricted Stock Units | −1,607 | 4,821 | ||
| 2026-01-01 | Kalia Kumud Chief Information Officer | Option exercise · Performance-Based Restricted Stock Units | −12,856 | 0 | ||
| 2026-01-01 | Kalia Kumud Chief Information Officer | Option exercise · Restricted Stock Units | −1,083 | 3,252 | ||
| 2026-01-01 | Kalia Kumud Chief Information Officer | Option exercise · Performance-Based Restricted Stock Units | −3,696 | 3,698 | ||
| 2026-01-01 | Kalia Kumud Chief Information Officer | Option exercise · Restricted Stock Units | −1,995 | 13,961 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,928 | 28,723 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise | +15,428 | 44,151 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,667 | 45,818 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise | +5,688 | 51,506 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise | +2,526 | 54,032 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Shares withheld for taxes | −10,162 | $102.14 | $1.0M | 43,870 |
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,928 | 5,786 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise · Performance-Based Restricted Stock Units | −15,428 | 0 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,667 | 5,002 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise · Performance-Based Restricted Stock Units | −5,688 | 5,688 | ||
| 2026-01-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −2,526 | 17,684 | ||
| 2026-01-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise | +23,997 | 2,024,245 | ||
| 2026-01-01 | Talasaz AmirAli Co-Chief Executive Officer | Shares withheld for taxes | −10,788 | $102.14 | $1.1M | 2,013,457 |
| 2026-01-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −23,997 | 95,989 | ||
| 2026-01-01 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise | +23,997 | 2,073,514 |
Page 28 of 42 · 827 trades